Healthcare provider profile · identity verified

Frank C Von Maluski

Internal Medicine · DAYTON, OH · NPI 1891740155

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	578	180
Levothyroxine Sodium	Levothyroxine Sodium	533	146
Amlodipine Besylate	Amlodipine Besylate	297	98
Rosuvastatin Calcium	Rosuvastatin Calcium	246	91
Metoprolol Succinate	Metoprolol Succinate	233	77
Lorazepam	Lorazepam	231	76
Simvastatin	Simvastatin	231	71
Hydrochlorothiazide	Hydrochlorothiazide	225	72
Omeprazole	Omeprazole	201	75
Lisinopril	Lisinopril	168	64
Losartan Potassium	Losartan Potassium	168	64
Tamsulosin Hcl	Tamsulosin Hcl	162	47
Eliquis	Apixaban	160	39
Furosemide	Furosemide	159	41
Gabapentin	Gabapentin	159	49
Metoprolol Tartrate	Metoprolol Tartrate	139	37
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	138	40
Metformin Hcl	Metformin Hcl	138	42
Prednisone	Prednisone	137	87
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	123	39
Allopurinol	Allopurinol	122	34
Alprazolam	Alprazolam	121	33
Sertraline Hcl	Sertraline Hcl	117	34
Pantoprazole Sodium	Pantoprazole Sodium	110	39
Spironolactone	Spironolactone	110	32
Ipratropium Bromide	Ipratropium Bromide	107	31
Azithromycin	Azithromycin	103	85
Zolpidem Tartrate	Zolpidem Tartrate	98	29
Mounjaro	Tirzepatide	95	17
Tramadol Hcl	Tramadol Hcl	95	42
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	93	27
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	93	21
Nifedipine Er	Nifedipine	90	21
Synthroid	Levothyroxine Sodium	87	26
Celecoxib	Celecoxib	85	28
Trazodone Hcl	Trazodone Hcl	83	32
Donepezil Hcl	Donepezil Hcl	80	21
Escitalopram Oxalate	Escitalopram Oxalate	76	25
Indapamide	Indapamide	69	19
Cefuroxime	Cefuroxime Axetil	66	44
Amoxicillin	Amoxicillin	65	52
Xarelto	Rivaroxaban	65	17
Clonazepam	Clonazepam	63	11
Pravastatin Sodium	Pravastatin Sodium	63	25
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	62	40
Methocarbamol	Methocarbamol	62	24
Mirtazapine	Mirtazapine	61	12
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	60	43
Ezetimibe	Ezetimibe	57	18
Famotidine	Famotidine	57	24
Venlafaxine Hcl Er	Venlafaxine Hcl	56	16
Clopidogrel	Clopidogrel Bisulfate	54	19
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	53	13
Duloxetine Hcl	Duloxetine Hcl	52	24
Ramipril	Ramipril	52	17
Fluticasone Propionate	Fluticasone Propionate	48	25
Propranolol Hcl	Propranolol Hcl	48	15
Potassium Chloride	Potassium Chloride	47	18
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	47	17
Doxycycline Hyclate	Doxycycline Hyclate	46	31
Montelukast Sodium	Montelukast Sodium	46	14
Meloxicam	Meloxicam	43	15
Albuterol Sulfate Hfa	Albuterol Sulfate	42	20
Citalopram Hbr	Citalopram Hydrobromide	42	14
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	41	20
Doxazosin Mesylate	Doxazosin Mesylate	41	15
Atenolol	Atenolol	39	13
Metformin Hcl Er	Metformin Hcl	39	15
Valsartan	Valsartan	38	13
Valacyclovir	Valacyclovir Hcl	37	15
Telmisartan	Telmisartan	36	suppressed
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	35	suppressed
Paroxetine Hcl	Paroxetine Hcl	35	13
Paxlovid	Nirmatrelvir/Ritonavir	35	35
Cephalexin	Cephalexin	34	26
Buspirone Hcl	Buspirone Hcl	33	suppressed
Memantine Hcl	Memantine Hcl	33	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	31	13
Estradiol	Estradiol	31	suppressed
Baclofen	Baclofen	30	11
Fenofibrate	Fenofibrate Nanocrystallized	30	suppressed
Clarithromycin	Clarithromycin	29	23
Tizanidine Hcl	Tizanidine Hcl	29	13
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	29	suppressed
Meclizine Hcl	Meclizine Hcl	28	14
Propranolol Hcl Er	Propranolol Hcl	28	suppressed
Torsemide	Torsemide	28	suppressed
Jardiance	Empagliflozin	27	suppressed
Ondansetron Hcl	Ondansetron Hcl	27	20
Pregabalin	Pregabalin	27	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	26	19
Raloxifene Hcl	Raloxifene Hcl	26	suppressed
Repatha Sureclick	Evolocumab	26	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	25	18
Carvedilol	Carvedilol	24	12
Diclofenac Sodium	Diclofenac Sodium	24	suppressed
Temazepam	Temazepam	24	suppressed
Hydralazine Hcl	Hydralazine Hcl	23	suppressed
Minoxidil	Minoxidil	23	suppressed
Ozempic	Semaglutide	22	suppressed
Primidone	Primidone	22	suppressed
Trulicity	Dulaglutide	22	suppressed
Zolpidem Tartrate Er	Zolpidem Tartrate	22	suppressed
Azelastine Hcl	Azelastine Hcl	21	13
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	21	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	21	11
Fluconazole	Fluconazole	21	11
Isosorbide Mononitrate Er	Isosorbide Mononitrate	21	suppressed
Methotrexate	Methotrexate Sodium	20	suppressed
Methylprednisolone	Methylprednisolone	20	19
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	20	15
Warfarin Sodium	Warfarin Sodium	20	suppressed
Clorazepate Dipotassium	Clorazepate Dipotassium	19	suppressed
Levofloxacin	Levofloxacin	19	14
Amiodarone Hcl	Amiodarone Hcl	18	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	18	suppressed
Bupropion Hcl	Bupropion Hcl	18	suppressed
Finasteride	Finasteride	18	suppressed
Glimepiride	Glimepiride	18	suppressed
Klor-Con M20	Potassium Chloride	18	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	18	suppressed
Testosterone	Testosterone	18	suppressed
Topiramate	Topiramate	18	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	17	suppressed
Chlorthalidone	Chlorthalidone	17	suppressed
Januvia	Sitagliptin Phosphate	17	suppressed
Oxycodone Hcl	Oxycodone Hcl	17	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	16	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	16	suppressed
Sucralfate	Sucralfate	16	suppressed
Alendronate Sodium	Alendronate Sodium	15	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	15	suppressed
Methimazole	Methimazole	15	suppressed
Nitroglycerin	Nitroglycerin	15	13
Nystatin	Nystatin	15	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	15	suppressed
Benazepril Hcl	Benazepril Hcl	14	suppressed
Brilinta	Ticagrelor	14	suppressed
Clonidine Hcl	Clonidine Hcl	14	suppressed
Eplerenone	Eplerenone	14	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	14	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	14	suppressed
Enalapril Maleate	Enalapril Maleate	13	suppressed
Labetalol Hcl	Labetalol Hcl	13	suppressed
Mometasone Furoate	Mometasone Furoate	13	suppressed
Aripiprazole	Aripiprazole	12	suppressed
Bupropion Xl	Bupropion Hcl	12	suppressed
Captopril	Captopril	12	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	12	suppressed
Dutasteride	Dutasteride	12	suppressed
Farxiga	Dapagliflozin Propanediol	12	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	12	suppressed
Nexletol	Bempedoic Acid	12	suppressed
Ondansetron Odt	Ondansetron	12	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	12	suppressed
Ropinirole Hcl	Ropinirole Hcl	12	suppressed
Gemfibrozil	Gemfibrozil	11	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	11	suppressed
Ketoconazole	Ketoconazole	11	suppressed
Metronidazole	Metronidazole	11	suppressed
Nebivolol Hcl	Nebivolol Hcl	11	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	11	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error